Home
Search

Press Releases

Get the latest on BIO’s announcements, positions, and views.

Featured Press Releases
Biotechnology Innovation Organization (BIO)…
WASHINGTON, DC (January 7th, 2026) – Today, the Biotechnology Innovation Organization (BIO) announced the launch of the BIO Investment Council (BIC). The newly established council aims to serve small and emerging biotech innovators by increasing…
Learn more
BIO Statement on Changes Announced to the U.S…
WASHINGTON, D.C. – John F. Crowley, President and CEO of the Biotechnology Innovation Organization (BIO)  released the following statement on changes announced to the US childhood vaccine schedule.“American health is as unique as America itself…
Learn more
BIO Statement on December 2025 ACIP Meeting
WASHINGTON, D.C. – Phyllis Arthur, Executive Vice President and Head of Health Policy and Programs of the Biotechnology Innovation Organization (BIO) released the following statement on the December 2025 ACIP meeting.“For decades, the CDC’s Advisory…
Learn more
All Press Releases
  • Show All
Search
Results
Event Tags
BIO Statement on Hatch-Waxman Integrity Act of 2019
February 6, 2019
BIO applauds the leadership of Senator Thom Tillis (R- NC) and Congressman Bill Flores (R-17 TX) for introducing the “Hatch-Waxman Integrity Act of 2019” to preserve the time-tested approach of the HWA while strengthening the ability of patent…
BIO Statement on State of the Union Address
February 5, 2019
BIO’s President and CEO Jim Greenwood issues statement on President Trump’s State of the Union Address.
BIO Statement on New Proposal for Lowering Out-of-Pocket Costs for Medicines
January 31, 2019
BIO’s President and CEO Jim Greenwood issued a statement after the Trump administration released a proposed rule that would alter safe harbor policies under the federal anti-kickback statute.
BIO Statement Ahead of Chinese Vice Premier Visit to Washington
January 29, 2019
"President Trump has taken unprecedented measures to take on China – our largest trading partner – for its history of trade abuses. Beijing has long imposed unjustified restrictions on U.S. companies seeking to do business in and export to China,…
BIO Statement on China Approvals of Agricultural Biotechnology Products
January 17, 2019
Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement on the announcement that the People’s Republic of China’s National Biosafety Committee approved the final safety certificate for five…
New Platform for Innovation in Food and Agriculture Launches, Invites Broad Conversation
January 16, 2019
WASHINGTON, DC – Jan. 16, 2019 – Today, the Biotechnology Innovation Organization (BIO) and the American Seed Trade Association (ASTA) jointly announce the launch of Innovature, a new platform to spark a thoughtful dialogue around innovation in food…
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
January 11, 2019
“Members of the House have sent a strong signal to the American people about their commitment to prioritizing health security by providing the resources needed to fully prepare for and defend against biological threats. Strengthening the pipeline of…
BIO Applauds House Passage of the Pandemic and All-Hazards Preparedness and Advancing Innovation Act
December 20, 2018
Washington, DC (December 20, 2018) – Biotechnology Innovation Organization (BIO) President and CEO Jim Greenwood issued the following statement applauding passage today by the House of Representatives of the Pandemic and All-Hazards…
BIO Statement on USDA Finalizing Rule for National Bioengineered Food Disclosure Standard
December 20, 2018
The Biotechnology Innovation Organization today released the following statement in response to USDA issuing a final rule implementing the National Bioengineered Food Disclosure Standard: 
BIO Statement on Hatch-Waxman Integrity Act of 2018
December 14, 2018
“For almost 40 years, the groundbreaking law known as the Hatch-Waxman Act (HWA) has been highly successful in spurring the development of life-saving new treatments while at the same time vastly broadening the availability of low-cost generic…
gooddaybio-cover-final
Daily News You Can’t Afford to Miss

Read it in under 3 minutes!

The Good Day BIO newsletter is the only daily newsletter at the intersection of biotech, politics, and policy. 

Sign Up Today